REVIEW ON DRUG CONTAINING HYDROGEL FOR THE TREATMENT OF CONJUNCTIVITIS

Registration ID: IJNRD_214755

Published ID: IJNRD2403233

DOI: Click Here to Get

Dipak Raju Kale , Rohini kawar , Vaishnvi badak , Suresh waghmare , Ram Ingale

Conjunctivitis, Disease, Hydrogel, Ophthalmology, Haemophilia’s’ influenza, Ocular etc.

Abstract: This review’s primary goal is to provide an overview of hydrogel-based conjunctivitis treatments. conventional medications including eye drops can be used under the present circumstances. Conventional drug forms such as eye drops have poor therapeutic responses and require regular dosage adjustments. Therefore, the pressing issue facing medical diligence investigators is creating a drug form that would carry the medication to the intended spot without significantly depleting the drug or producing any systemic side effects. (1) Around the world, conjunctivitis is a common ailment seen at ophthalmology conferences. Fearful signals have a greater number of serious intraocular disorders that need to be taken into consideration when treating presumed cases of conjunctivitis. These conditions correspond to significant pain (2), reduced vision and also patients with unusual anomalies and a history of eye conditions should also have an ocular examination. long-term duration. Findings from a concurrent physical examination and pertinent medical history may show involvement of the conjunctiva in an underlying illness. The definition of “hydrogel” refers to a type of polymeric compound whose hydrophilic structure allows them to retain enormous amounts of water that remain in their three-dimensional natural networks. In addition to other types of synthetic biomaterials, they remarkably resemble genuine living tissues because of they have contain large proportion of water, porosity, and soft viscosity. (3) To create a hydrogel that will lengthen a medicine’s retention period in an ocular pharmaceutical delivery method. In order to ensure the best possible bioavailability at the site of action, hydrogel ophthalmic doses made with HPMC have demonstrated excellent characteristics and a respectable sustained release profile. The conclusions of this investigation showed that using medications with hydrogel ophthalmic substances during eye care was effective. (4)

Published Paper   E-Certificate

Dipak Raju Kale , Rohini kawar, Vaishnvi badak, Suresh waghmare , & Ram Ingale (March-2024). REVIEW ON DRUG CONTAINING HYDROGEL FOR THE TREATMENT OF CONJUNCTIVITIS. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(3), c230-c247. https://ijnrd.org/papers/IJNRD2403233.pdf

Volume 9 Issue 3, March-2024

Pages : c230-c247

Paper Reg. ID: IJNRD_214755

Published Paper Id: IJNRD2403233

Downloads: 000121988

Research Area: Pharmacy

Country: string:Aurangabad, string:Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2403233.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2403233

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details